s
Fapon Biopharma Announces FDA Approval of IND for FP008, a First-in-Class Immunotherapy for Solid Tumors
28-02-2025, 13:03
DONGGUAN, China, Feb. 28, 2025 /PRNewswire/ — Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for FP008, its first-in-class immunocytokine designed to address the unmet need in patients with solid tumors refractory […] L'articolo Fapon Biopharma Announces FDA Approval of IND for FP008, a First-in-Class Immunotherapy for Solid Tumors proviene da La Ragione.
CONTINUA A LEGGERE
8
0
0
Guarda anche
La Ragione
20:47
Mo: media, ‘un morto in attacco Idf nel sud del Libano’
La Ragione
20:44
Totti, il viaggio a Mosca e l’indignazione: “Non andare in Russia”
La Ragione
20:35
Mo: Houthi, ‘colpiremo navi cargo americane nel Mar Rosso’
La Ragione
20:22